FY26 B1 foundation care pharm chemo APR 26
Ended Awarded Last action
- Contract number
- 15B40626F00000137
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Federal Correctional Complex Florence
Correctional Facilities, Department of Justice
- Obligated
- $14,386
Award facts
- Contract value 100% obligated
- $14,385.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sand Lake, FL 32819, USA
Award details come from SAM.gov/FPDS.
About this award
The Federal Correctional Complex Florence, a civilian agency of the Bureau of Prisons, awarded a delivery order to Takeda Pharmaceuticals America, Inc. for foundation care pharmaceutical chemotherapy on April 1, 2026. This firm fixed-price delivery order, valued at $14,385.75 with an ultimate completion date of April 30, 2026, carries no small business set-aside designation and represents performance in Orlando, Florida. The award is a child contract under the parent General Services Administration Schedule for Pharmaceuticals and Drugs (FSS-61-IB), which establishes a framework for procurement of specialized pharmaceutical products including oncology medications.
Takeda Pharmaceuticals America, Inc., a foreign-owned subsidiary of Takeda Pharmaceutical Company Limited based in Cambridge, Massachusetts, is a major supplier of specialized pharmaceutical products to federal healthcare agencies. The company is registered in the System for Award Management (SAM.gov) and operates as a large, for-profit manufacturer. Takeda maintains significant federal contracting relationships, particularly with the Department of Veterans Affairs through multiple indefinite delivery vehicles, and has expanded its federal healthcare supplier role to include the Bureau of Prisons. This delivery order reflects the company's established position as a critical supplier of high-value specialty pharmaceuticals to federal correctional and healthcare facilities.
Quick answers
Who was awarded contract 15B40626F00000137?
15B40626F00000137 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Complex Florence (Correctional Facilities) on April 1, 2026.
How much is contract 15B40626F00000137 worth?
The government has obligated $14,386 on 15B40626F00000137.
Is contract 15B40626F00000137 an order under another contract?
Yes. 15B40626F00000137 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B40626F00000137 competed?
The extent of competition for 15B40626F00000137 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award